335 related articles for article (PubMed ID: 29227930)
1. Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities.
Yan X; Lv Z; Wen J; Zhao S; Xu Z
Eur J Med Chem; 2018 Jan; 143():899-904. PubMed ID: 29227930
[TBL] [Abstract][Full Text] [Related]
2. Azide-alkyne cycloaddition towards 1H-1,2,3-triazole-tethered gatifloxacin and isatin conjugates: Design, synthesis and in vitro anti-mycobacterial evaluation.
Xu Z; Song XF; Hu YQ; Qiang M; Lv ZS
Eur J Med Chem; 2017 Sep; 138():66-71. PubMed ID: 28646656
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
[TBL] [Abstract][Full Text] [Related]
4. 1H-1,2,3-Triazole tethered isatin-moxifloxacin: Design, synthesis and in vitro anti-mycobacterial evaluation.
Jiang Y; Qian A; Li Y
Arch Pharm (Weinheim); 2019 Jul; 352(7):e1900040. PubMed ID: 31106443
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and antimicrobial evaluation of propylene-tethered ciprofloxacin-isatin hybrids.
Wang R; Yin X; Zhang Y; Yan W
Eur J Med Chem; 2018 Aug; 156():580-586. PubMed ID: 30025351
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and In Vitro Anti-microbial Evaluation of Ethylene/ Propylene-1H-1,2,3-Triazole-4-Methylene-tethered Isatin-coumarin Hybrids.
Jin X; Xu Y; Yang X; Chen X; Wu M; Guan J; Feng L
Curr Top Med Chem; 2017; 17(29):3213-3218. PubMed ID: 29243578
[TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin-1,2,3-triazole-isatin hybrids tethered via amide: Design, synthesis, and in vitro anti-mycobacterial activity evaluation.
Chen R; Zhang H; Ma T; Xue H; Miao Z; Chen L; Shi X
Bioorg Med Chem Lett; 2019 Sep; 29(18):2635-2637. PubMed ID: 31358466
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids.
Xu Z; Zhang S; Song X; Qiang M; Lv Z
Bioorg Med Chem Lett; 2017 Aug; 27(16):3643-3646. PubMed ID: 28720502
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anti-mycobacterial activity evaluation of benzofuran-isatin hybrids.
Gao F; Yang H; Lu T; Chen Z; Ma L; Xu Z; Schaffer P; Lu G
Eur J Med Chem; 2018 Nov; 159():277-281. PubMed ID: 30296686
[TBL] [Abstract][Full Text] [Related]
10. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
11. Gatifloxacin-1,2,3-triazole-isatin hybrids and their antimycobacterial activities.
Ding Z; Hou P; Liu B
Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900135. PubMed ID: 31441087
[TBL] [Abstract][Full Text] [Related]
12. Benzofuran-isatin hybrids tethered via different length alkyl linkers and their in vitro anti-mycobacterial activities.
Gao F; Chen Z; Ma L; Qiu L; Lin J; Lu G
Bioorg Med Chem; 2019 Jun; 27(12):2652-2656. PubMed ID: 30992202
[TBL] [Abstract][Full Text] [Related]
13. Benzofuran-isatin hybrids and their in vitro anti-mycobacterial activities against multi-drug resistant Mycobacterium tuberculosis.
Gao F; Ye L; Wang Y; Kong F; Zhao S; Xiao J; Huang G
Eur J Med Chem; 2019 Dec; 183():111678. PubMed ID: 31525660
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and antibacterial activity evaluation of moxifloxacin-amide-1,2,3-triazole-isatin hybrids.
Gao F; Ye L; Kong F; Huang G; Xiao J
Bioorg Chem; 2019 Oct; 91():103162. PubMed ID: 31382058
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
[TBL] [Abstract][Full Text] [Related]
16. Moxifloxacin Derivatives with Potential Antibacterial Activity against Methicillin- Resistant Staphylococcus Aureus (MRSA).
Chen R; Xue H; Xu Y; Ma T; Liu Y; Zhang J; Shi X; Guo D
Curr Top Med Chem; 2021; 21(27):2474-2482. PubMed ID: 34645377
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antimycobacterial activity of balofloxacin ethylene isatin derivatives.
Feng LS; Liu ML; Wang B; Chai Y; Hao XQ; Meng S; Guo HY
Eur J Med Chem; 2010 Aug; 45(8):3407-12. PubMed ID: 20493593
[TBL] [Abstract][Full Text] [Related]
18. 1H-1,2,3-triazole embedded Isatin-Benzaldehyde-bis(heteronuclearhydrazones): design, synthesis, antimycobacterial, and cytotoxic evaluation.
Sharma B; Kumar S; Preeti ; Johansen MD; Kremer L; Kumar V
Chem Biol Drug Des; 2022 Feb; 99(2):301-307. PubMed ID: 34786862
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and in vitro anti-mycobacterial activities of homonuclear and heteronuclear bis-isatin derivatives.
Xu Y; Guan J; Xu Z; Zhao S
Fitoterapia; 2018 Jun; 127():383-386. PubMed ID: 29631015
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antimycobacterial activity of 1-(β-d-Ribofuranosyl)-4-coumarinyloxymethyl- / -coumarinyl-1,2,3-triazole.
Srivastava S; Bimal D; Bohra K; Singh B; Ponnan P; Jain R; Varma-Basil M; Maity J; Thirumal M; Prasad AK
Eur J Med Chem; 2018 Apr; 150():268-281. PubMed ID: 29529504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
